4//SEC Filing
Theagene Jean-Manasse 4
Accession 0001878313-25-000035
CIK 0001878313other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:29 PM ET
Size
5.2 KB
Accession
0001878313-25-000035
Insider Transaction Report
Form 4
Theagene Jean-Manasse
Director
Transactions
- Award
Stock Options
2025-10-02+20,459→ 20,459 totalExercise: $1.80From: 2025-10-02Exp: 2035-10-02→ Common Stock (20,459 underlying)
Footnotes (1)
- [F1]The stock options, granted on October 2, 2025, pursuant to the MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001969857
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:29 PM ET
- Size
- 5.2 KB